Today's New Buy Pick - Milestone Scientific Inc. (MLSS)

"We're In The final Throes Of A Very Important Deal" President Donald Trump said yesterday that negotiators  are close to reaching an initial trade deal after both sides spoke by  phone. "We're in the final throes of a very important deal," Trump told  reporters at the White House. "It's going very well." Later in the day,  Trump told Fox News host Bill O'Reilly that he's "holding it up because  it's got to be a good deal. We can't make a deal that's like, even.  ...   Shares of Deere (DE) are down around -5%  this morning after the manufacturing company issued lower guidance as  trade tensions continue to slow farmers' equipment purchases. Deere says  it now expects net income to come in between $2.7 billion to $3.1  billion in fiscal 2020, lower than analysts' estimates for $3.5 billion  for the year.  ...   Read More Bizarre Cannabis "Hack" Could Make You A Marijuana Millionaire Elite researchers have quietly developed a cannabis "hack" that could revolutionize the $150 billion industry... and make investors incredibly rich. We're looking at an opportunity that's bigger than the tech boom of the 90's. Bigger than the oil spike of 2008. Even bigger than the bitcoin craze of 2017! (ad) Click here to find out how this "moonshot" could hand you 997% profits in the next 12 months. Hard Money Expert: "Reno Gold Secret could hand investors a small fortune." Nobody could've predicted a tiny ad in a small Nevada newspaper could turn $100 into more than $32k and lead to one of the greatest investment secrets in history. (ad) Go here to discover the $7 firm using the same secret. FL: good value, or big risk? When technical traders see a stock's price pattern diverging from its  industry or sector, the question becomes whether that divergence  represents an opportunity, or a risk. The commonly held principle that  "a rising tide lifts all ships" usually means that if a broad segment of  the market, such as the Consumer Discretionary sector, is performing  well, most stocks in that sector should also be seeing strongly bullish  movements. Through the first half of 2019, Consumer Discretionary was  one of the top-performing sectors, but since August has moved in a  mostly sideways pattern, and is slightly below its 52-week high point in  July as measured by the S&P 500 Consumer Discretionary Sector SPDR (XLY). Read More Roger Scott reveals his QUICKEST Cash Trades Grab onto your seat, because THIS stock is about to MOVE! The former hedge fund manager, and current guru, who turned $20 million into over $740 just spotted this stock... ...and he's calling our recent 99% gain on EA "pocket change" in comparison to what's coming... Roger's about to reveal his #1 stock pick to make "Overnight Fortunes" (ad) Click here to grab your FREE seat Featured Stock Milestone Scientific Inc. (MLSS) Buy Target – $1.35 or better Milestone Scientific, Inc. develops computer-controlled anesthetic   delivery devices for the medical and dental markets in the United States   and internationally. The company operates in two segments, Dental and   Medical. Its products include CompuDent System that are used to control   the flow rate of the anesthesia during the injection, which allows   virtually painless injections for various dental procedures, including   routine fillings, implants, root canals, and crowns. The company also   offers CompuFlo, a computer-controlled drug delivery system for the   painless delivery of drugs, anesthetics, and other medicaments, as well   as for the aspiration of bodily fluids or previously injected   substances; and disposable injection handpiece for the tactile control   during the injection.   Other Top Stories Stocks edge higher over continued trade optimism US consumer spending up 0.3% in October with incomes flat    Aerospace stocks leading this market rally Pending US home sales fell 1.7% in October amid short supply   Sponsor Gold: $5,000 or $700? Gold has zoomed higher in recent years… The big question now is: will gold continue to soar higher or is it ready to plummet? Economist Harry S. Dent Jr. now has indisputable evidence of precisely where gold is heading next. Before you make another gold investment, it's critical you review his latest research. Full details here. Read More   Trend Following Picks (VERU) Buy Target – $2.22 or better (JCS) Buy Target $7.40 or better (JE) – Buy Target – $2.80 or better (AVDL) Buy Target – $5.75 or better (AGI) Buy Signal – $5.65 or better (PZG) – Buy Target $0.80 or better All Picks Reversal Picks (PIRS) Buy Target $4.05 Sell Target $4.79 (MGTX) Buy Target $17.29  Sell Target $19.46 (DQ) Buy Target $42.51 Sell Target $46.71 All Picks   Already subscribed to our premium service? Click here to Login.  Not a TradersPro subscriber yet? Try It Now -  Limited Time Offer

 

                                                           

This email was sent to its028@gmail.com by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. Disclaimers, Terms & Conditions | Privacy Policy Copyright © 2019